Every year, half a million new people in Germany get cancer – about half of them die. Too many experts who work every day to save lives with new therapies.
Not only are these treatments coming too late, but in too few patients, it is necessary to do more in screening and early detection. Well-known experts here pose ten demands on what needs to be changed so that fewer people die from cancer.
Providing medical care must already be a problem in school and firmly embedded in the curriculum.
We need constant information on the importance of healthy eating – through health insurance companies, pharmacies, medical practices and the media. The risk of alcohol, too much sugar and fat, as well as smoking must become even clearer.
More and more people need to be encouraged for preventive vaccinations – such as HPV cervical cancer vaccine, oropharyngeal cancer. Better yet better bonus systems for health insurance companies to promote the movement. I: Stop advertising tobacco and drastically increase tobacco taxes.
GPs need to be better informed about screening and regular screening of family cancer exposure must be compulsory. Successful concepts such as the need to adopt a Dutch invasive procedure for screening for colon cancer. More than 70 percent of them are invited to participate, and in Germany about 20 percent.
Much more resources are needed to develop innovative, precision diagnostics. This is a prerequisite for new, custom therapeutic concepts. The key to this is close collaboration between research institutions, university clinics, qualified hospitals and oncology specialist practices.
The goal must be: greater survival, better quality of life. For this purpose, new research therapy needs to reach faster in patients.
All patients are entitled to their information! It is necessary to ensure that family physicians, specialists and clinicians are able to enter patient data into a structured form in a digital patient card in a timely and automatic manner in a timely and automatic manner in order to optimize medical care. At the same time, anonymous data in scientific assessments can help provide better care for future cancer patients.
8. Care and Rehabilitation
Also, concern becomes more and more important and needs to be increased and valued more! More and more people are living with this disease longer and longer – but they must also learn to re-engage in everyday life.
9. Psychotherapeutic accompaniment
We need more and better qualified professionals to help care for cancer patients and their relatives across the country. Because psyche is a very important part of our being and our health.
Patients and their self-help organizations must be more involved! Physicians should see those affected as equal partners in the treatment. Being involved with personal desires is an important basis for the success of the treatment.
Dr. Albert Beyer, president of the professional association of gastroenterologists (intestinal specialists) of Germany
- Ulrich Fölsch, Secretary General of the German Society for Internal Medicine
- Dr. Armin Goetzenich, a professional association of established hematologists and oncologists
Michael Hallek, director of the Center for Integrated Oncology at the University of Cologne
- Dr. Thomas Illmer, a professional association of established hematologists and oncologists
- Wolfgang Knauf, Center for Hematology and Oncology at Bethanien Hospital in Berlin
- Frank Kolligs, Chief Medical Practitioner of Internal Medicine and Gastroenterology at Helios Klinikum Berlin Buch
- Markus Kosch, vice president of oncology at Pfizer Pharmi
- Diana Lüftner, Senior Physician Charité Berlin, Member of the Steering Board of the German Society for Hematology and Medical Oncology
- Dr. Christa Maar, chair of the colon cancer network
- Eckhard Nagel, Institute of Medical Management and Health Sciences, University of Bayreuth
- Claudia Neumann, German Foundation for Young Adult Cancer, Berlin
- Charlotte Niemeyer, Medical Director of the Breast Cancer Clinic in Freiburg
- Hagen Pfundner, Member of the Board of Roche Pharma
- Dr. Georg Ralle, Secretary General of the Colon Cancer Network
- Thomas Seufferlein, Medical Director of the University of Ulm
- Tino Sorge, a member of the German Bundestag (CDU)
- Han Steutel, Bristol-Myers Squibb Pharma
- Dr. Erik Thiele Orberg, Technical University of Munich
- Prof. Cornelia Ulrich, University of Utah
- Michael von Bergwelt, Director of the Department of Internal Medicine of the Ludwig-Maximilians University Hospital in Munich
- Christof von Kalle, director of the Berlin Institute for Health at Charité Berlin